ARRDC1
Basic information
Region (hg38): 9:137605685-137615360
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ARRDC1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 42 | 46 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 42 | 4 | 0 |
Variants in ARRDC1
This is a list of pathogenic ClinVar variants found in the ARRDC1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-137605725-G-T | not specified | Uncertain significance (Jun 13, 2023) | ||
9-137605754-C-T | not specified | Uncertain significance (Feb 24, 2022) | ||
9-137605774-C-A | not specified | Uncertain significance (Jul 19, 2023) | ||
9-137605784-C-T | not specified | Uncertain significance (Feb 16, 2023) | ||
9-137605805-G-A | not specified | Uncertain significance (Feb 13, 2023) | ||
9-137605805-G-C | not specified | Uncertain significance (Mar 30, 2024) | ||
9-137605818-C-T | not specified | Uncertain significance (Jul 12, 2022) | ||
9-137605827-C-T | not specified | Uncertain significance (Nov 10, 2022) | ||
9-137605832-C-G | not specified | Uncertain significance (May 28, 2024) | ||
9-137612943-A-C | not specified | Uncertain significance (Jan 18, 2023) | ||
9-137612979-A-T | not specified | Uncertain significance (Jul 25, 2023) | ||
9-137612981-C-G | not specified | Uncertain significance (Dec 15, 2022) | ||
9-137612988-C-G | not specified | Uncertain significance (May 31, 2023) | ||
9-137613615-C-T | not specified | Uncertain significance (Nov 10, 2022) | ||
9-137613624-C-G | not specified | Uncertain significance (Jul 17, 2023) | ||
9-137613642-C-T | not specified | Uncertain significance (Apr 18, 2023) | ||
9-137613689-C-T | not specified | Uncertain significance (Apr 19, 2024) | ||
9-137613690-G-A | not specified | Uncertain significance (Aug 04, 2021) | ||
9-137613726-A-T | not specified | Uncertain significance (Jan 18, 2022) | ||
9-137613737-C-G | not specified | Uncertain significance (Feb 15, 2023) | ||
9-137614092-G-A | not specified | Uncertain significance (Mar 07, 2024) | ||
9-137614102-C-T | not specified | Uncertain significance (Feb 12, 2024) | ||
9-137614120-G-A | not specified | Uncertain significance (Jan 18, 2022) | ||
9-137614125-T-G | not specified | Uncertain significance (May 23, 2023) | ||
9-137614335-G-A | not specified | Uncertain significance (Apr 12, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ARRDC1 | protein_coding | protein_coding | ENST00000371421 | 8 | 9707 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000136 | 0.625 | 125686 | 0 | 59 | 125745 | 0.000235 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.116 | 267 | 262 | 1.02 | 0.0000162 | 2752 |
Missense in Polyphen | 83 | 84.242 | 0.98525 | 898 | ||
Synonymous | -0.913 | 138 | 125 | 1.10 | 0.00000902 | 948 |
Loss of Function | 0.997 | 11 | 15.2 | 0.724 | 6.47e-7 | 187 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000333 | 0.000329 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.0000932 | 0.0000924 |
European (Non-Finnish) | 0.000297 | 0.000290 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000332 | 0.000327 |
Other | 0.000491 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Functions as an adapter recruiting ubiquitin-protein ligases to their specific substrates (PubMed:23886940, PubMed:27462458). Through an ubiquitination-dependent mechanism plays for instance a role in the incorporation of SLC11A2 into extracellular vesicles (PubMed:27462458). More generally, plays a role in the extracellular transport of proteins between cells through the release in the extracellular space of microvesicles (PubMed:22315426). By participating to the ITCH-mediated ubiquitination and subsequent degradation of NOTCH1, negatively regulates the NOTCH signaling pathway (PubMed:23886940). {ECO:0000269|PubMed:22315426, ECO:0000269|PubMed:23886940, ECO:0000269|PubMed:27462458}.;
Intolerance Scores
- loftool
- 0.757
- rvis_EVS
- 0.11
- rvis_percentile_EVS
- 62.1
Haploinsufficiency Scores
- pHI
- 0.0921
- hipred
- Y
- hipred_score
- 0.550
- ghis
- 0.463
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.307
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Arrdc1
- Phenotype
- cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- ubiquitin-dependent protein catabolic process;extracellular transport;protein transport;protein ubiquitination;negative regulation of Notch signaling pathway;extracellular vesicle biogenesis
- Cellular component
- plasma membrane;cytoplasmic vesicle;extracellular exosome;extracellular vesicle
- Molecular function
- protein binding;ubiquitin protein ligase binding;identical protein binding;protein binding, bridging involved in substrate recognition for ubiquitination;arrestin family protein binding